Food In Canada

Use of AI to discover bioactive peptides

Food in Canada Staff   


Sumitomo Chemical Co., Ltd. and Nuritas have signed a multi-year partnership to sustainably support the food production systems needed to feed the growing global population. This hugely important partnership will see Nuritas deploy its award-winning and novel technology platform, which uses Artificial Intelligence and DNA analysis to predict, unlock, and validate highly efficacious peptides, from plant sources. Sumitomo Chemical Co., Ltd. will use its considerable scientific know-how and applications expertise to validate the efficacy of these new discoveries within field tests and then commercialise the ensuing products globally.

“The global population is expected to reach close to 10 billion by 2050.” said Neil Foster, Head of Strategic Partnerships at Nuritas. “Feeding the world without destroying it is a fundamental challenge faced by industry and we are delighted to be partnering with Sumitomo Chemical Co. to be part of the solution.”

“We are honoured to be collaborating with Sumitomo Chemical Co., Ltd. At Nuritas our mission is to positively impact billions of lives. To achieve this, we need to focus on the big problems, and none are bigger than the challenge of producing sufficient food, sustainably, to feed the increasing world population”, said Nora Khaldi, Founder and Chief Executive Officer of Nuritas.


Isao Kurimoto, Executive Officer, Research Planning and Coordination Dept. at Sumitomo Chemical Co., Ltd. said, “Sumitomo Chemical has set four focused areas, which are Healthcare, Reducing Environmental Impact, Food and ICT in our current Corporate Business Plan. Partnering with Nuritas aligns with our strategic focused plan and will allow us to create and deliver sustainable solutions in food production with our experience and expertise in commercialisation.”

Mary Kinnane Enterprise Ireland’s Asia Pacific Regional Director said, “This is very positive news for Nuritas and a testament to the commitment and innovation at the heart of this globally ambitious company.  Enterprise Ireland is proud to have been able to assist Nuritas in its efforts to develop the Japanese and Asian markets, including this important partnership with Sumitomo Chemical Co. Ltd, one of Japan’s leading corporates.  This major development for Nuritas further strengthens the reputation of Irish business in Japan, a market which is open to and receptive of increasingly sophisticated and ambitious Enterprise Ireland supported companies’’

About Sumitomo Chemical Company Limited

Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies. It offers a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated sales revenue for fiscal year 2019 was JPY 2.2 trillion and number of employee is about 34,000 as of March 31, 2020. For additional information, visit the company’s website at

About Nuritas

Nuritas solves the biggest modern-day challenges by accessing the full molecular diversity of the natural world. The Nuritas platform targets the discovery of peptides to improve human and animal health.  Founded in 2014 by mathematician and computer scientist Dr. Nora Khaldi, Nuritas utilizes its powerful AI capabilities to quickly and accurately interrogate its vast library of natural molecules to identify compounds that exceed industry standards for management and treatment of a broad range of health conditions.  Nuritas advanced PeptAIde™, its first healthcare product, from concept to market in less than three years.  By leveraging peptides high target specificity, the Nuritas team of data scientists and experienced molecular biologists combine in-silico predictive capabilities, in-house laboratory research and in-vivo and human clinical validation to commercialize first-in-class advances in therapy to discover life-changing ingredients and products.


Print this page


Stories continue below